Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lorena Biasini has a total of 108 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Viral nervous necrosis Mortality in Wild Grouper from Central and Western Algeria

    by Sihem Benmokrane, Karim Mezali, Lorena Biasini, Alessandra Buratin, Paola Berto, Anna Toffan

    Viral nervous necrosis (VNN) is a disease caused by Betanodavirus that leads to outbreaks mortality in wild or farmed marine fish. This study aimed to investigate the presence of Betanodavirus in grouper from different sites along the Algerian coast and to characterize the isolates using molecular tools. A total of twenty-three individuals were examined: one dusky grouper (Epinephelus marginatus Lowe, 1834) and twenty-two goldblotch groupers (Epinephelus costae Steindachner, 1878). The RT-qPCR detected the presence of VNN in seven individuals of Epinephelus costae, three from the center of the Algerian coast (two from Algiers and one from Gouraya) and four from the west (Mostaganem). Phylogenetic analyses of the partial sequences of RNA1 and RNA2 viral genome fragments revealed the presence of the red-spotted grouper nervous necrosis virus (RGNNV) genotype, closely related to strains previously detected in Algerian groupers and wild grouper from Spain. The results of this study confirm further that VNN disease is endemic among grouper populations in Algeria, which could be a determining factor in the observed decline of this species.


  • Open Access

    Transcriptome Profiling of Oncorhynchus mykiss Infected with Low or Highly Pathogenic Viral Hemorrhagic Septicemia Virus (VHSV)

    by Lorena Biasini, Gianpiero Zamperin, Francesco Pascoli, Miriam Abbadi, Alessandra Buratin, Andrea Marsella, Valentina Panzarin, Anna Toffan

    The rainbow trout (Oncorhynchus mykiss) is the most important produced species in freshwater within the European Union, usually reared in intensive farming systems. This species is highly susceptible to viral hemorrhagic septicemia (VHS), a severe systemic disease widespread globally throughout the world. Viral hemorrhagic septicemia virus (VHSV) is the etiological agent and, recently, three classes of VHSV virulence (high, moderate, and low) have been proposed based on the mortality rates, which are strictly dependent on the viral strain. The molecular mechanisms that regulate VHSV virulence and the stimulated gene responses in the host during infection are not completely unveiled. While some preliminary transcriptomic studies have been reported in other fish species, to date there are no publications on rainbow trout. Herein, we report the first time-course RNA sequencing analysis on rainbow trout juveniles experimentally infected with high and low VHSV pathogenic Italian strains. Transcriptome analysis was performed on head kidney samples collected at different time points (1, 2, and 5 days post infection). A large set of notable genes were found to be differentially expressed (DEGs) in all the challenged groups (e.s. trim63a, acod1, cox-2, skia, hipk1, cx35.4, ins, mtnr1a, tlr3, tlr7, mda5, lgp2). Moreover, the number of DEGs progressively increased especially during time with a greater amount found in the group infected with the high VHSV virulent strain. The gene ontology (GO) enrichment analysis highlighted that functions related to inflammation were modulated in rainbow trout during the first days of VHSV infection, regardless of the pathogenicity of the strain. While some functions showed slight differences in enrichments between the two infected groups, others appeared more exclusively modulated in the group challenged with the highly pathogenic strain.


  • Open Access

    Efficacy of DNA Vaccines in Protecting Rainbow Trout against VHS and IHN under Intensive Farming Conditions

    by Andrea Marsella, Francesco Pascoli, Tobia Pretto, Alessandra Buratin, Lorena Biasini, Miriam Abbadi, Luana Cortinovis, Paola Berto, Amedeo Manfrin, Marco Vanelli, et al.

    Despite the negative impact of viral hemorrhagic septicemia (VHS) and infectious hematopoietic necrosis (IHN) on European rainbow trout farming, no vaccines are commercially available in Europe. DNA vaccines are protective under experimental conditions, but testing under intensive farming conditions remains uninvestigated. Two DNA vaccines encoding the glycoproteins (G) of recent Italian VHSV and IHNV isolates were developed and tested for potency and safety under experimental conditions. Subsequently, a field vaccination trial was initiated at a disease-free hatchery. The fish were injected intramuscularly with either the VHS DNA vaccine or with a mix of VHS and IHN DNA vaccines at a dose of 1 µg/vaccine/fish, or with PBS. At 60 days post-vaccination, fish were moved to a VHSV and IHNV infected facility. Mortality started 7 days later, initially due to VHS. After 3 months, IHN became the dominant cause of disease. Accordingly, both DNA vaccinated groups displayed lower losses compared to the PBS group during the first three months, while the VHS/IHN vaccinated group subsequently had the lowest mortality. A later outbreak of ERM caused equal disease in all groups. The trial confirmed the DNA vaccines to be safe and efficient in reducing the impact of VHS and IHN in farmed rainbow trout.


  • Open Access

    Pathogenicity of Different Betanodavirus RGNNV/SJNNV Reassortant Strains in European Sea Bass

    by Lorena Biasini, Paola Berto, Miriam Abbadi, Alessandra Buratin, Marica Toson, Andrea Marsella, Anna Toffan, Francesco Pascoli

    European sea bass (Dicentrarchus labrax) is an important farmed marine species for Mediterranean aquaculture. Outbreaks of betanodavirus represent one of the main infectious threats for this species. The red-spotted grouper nervous necrosis virus genotype (RGNNV) is the most widely spread in Southern Europe, while the striped jack nervous necrosis virus genotype (SJNNV) has been rarely detected. The existence of natural reassortants between these genotypes has been demonstrated, the RGNNV/SJNNV strain being the most common. This study aimed to evaluate the pathogenicity of different RGNNV/SJNNV strains in European sea bass. A selection of nine European reassortants together with parental RGNNV and SJNNV strains were used to perform in vivo experimental challenges via intramuscular injection. Additional in vivo experimental challenges were performed by bath immersion in order to mimic the natural infection route of the virus. Overall, results on survival rates confirmed the susceptibility of European sea bass to reassortants and showed different levels of induced mortalities. Results obtained by RT-qPCR also highlighted high viral loads in asymptomatic survivors, suggesting a possible reservoir role of this species. Our findings on the comparison of complete genomic segments of all reassortants have shed light on different amino acid residues likely involved in the variable pathogenicity of RGNNV/SJNNV strains in European sea bass.


  • Open Access

    Multifactorial Causes of Chronic Mortality in Juvenile Sturgeon (Huso huso)

    by Sara Ciulli, Enrico Volpe, Rubina Sirri, Giorgia Tura, Francesca Errani, Gianpiero Zamperin, Anna Toffan, Marina Silvi, Andrea Renzi, Miriam Abbadi, et al.

    This investigation focused on an episode of chronic mortality observed in juvenile Huso huso sturgeons. The examined subjects underwent pathological, microbiological, molecular, and chemical investigations. Grossly severe body shape deformities, epaxial muscle softening, and multifocal ulcerative dermatitis were the main observed findings. The more constant histopathologic findings were moderate to severe rarefaction and disorganization of the lymphohematopoietic lymphoid tissues, myofiber degeneration, atrophy and interstitial edema of skeletal epaxial muscles, and degeneration and atrophy of the gangliar neurons close to the myofibers. Chemical investigations showed a lower selenium concentration in affected animals, suggesting nutritional myopathy. Other manifestations were nephrocalcinosis and splenic vessel wall hyalinosis. Septicemia due to bacteria such as Aeromonas veronii, Shewanella putrefaciens, Citrobacter freundii, Chryseobacterium sp., and pigmented hyphae were found. No major sturgeon viral pathogens were detected by classical methods. Next-generation sequencing (NGS) analysis confirmed the absence of viral pathogens, with the exception of herpesvirus, at the order level; also, the presence of Aeromonas veronii and Shewanella putrefaciens was confirmed at the family level by the metagenomic classification of NGS data. In the absence of a primary yet undetected biological cause, it is supposed that environmental stressors, including nutritional imbalances, may have led to immune system impairment, facilitating the entry of opportunistic bacteria and mycotic hyphae.


  • A large, multicenter, retrospective study to identify a cutoff of MGMT methylation status by quantitative pyrosequencing approach in patients (PTS) with glioblastoma (GBM).

    by Giuseppe Lombardi, Luisa Bellu, Veronica Villani, Simona Rizzato, Marco Russo, Mariantonia Carosi, Elisa De Carlo, Lorena Biasini, Marina Paola Gardiman, Pasquale Fiduccia, et al.

    2012 A LARGE, MULTICENTER, RETROSPECTIVE STUDY TO IDENTIFY A CUT-OFF OF MGMT METHYLATION STATUS BY QUANTITATIVE PYROSEQUENCING APPROACH IN PATIENTS (PTS) WITH GLIOBLASTOMA (GBM). Background: MGMT promoter methylation status representsan important prognostic factor for GBM PTS in terms of progression free survival (PFS) and overall survival (OS). Quantitative pyrosequencing approach is a valid alternative to methylation-specific PCR but a cut-off value in still unclear. We performed a large, multicenter, retrospective study to identify a real cut-off value to discriminate its impact on clinical outcome in terms of PFS and OS. Methods: Retrospectively, from italian neuro-oncology centers, we collected GBM PTS from 2005 to 2016 with assessment of MGMT promoter methylation by pyrosequencing approach evaluating CpG islands from 74 to 83. Other inclusion criteria were: confirmed histological diagnoses of GBM, ECOG PS ≥2, treatment with concomitant radiation therapy and temozolomide. Kaplan-Maier method was used to estimate the survival curves and ROC curve for defining cut-off value for PFS and OS. Results: 376 GBM PTS were enrolled;median age was 62 ys (25-86); ECOG PS was 0 in 129 PTS, 1 in 160 PTS, 2 in 87 PTS; 212 PTS (58%) had a complete resection. 67 PTS (18%) received a second surgery. Median PFS and OS was 8.6 and 14.3 months. The optimal cut-off value to identify a strong prognostic value of MGMT methylation status in terms of PFS and OS, was 26% (sensitivity 72%, specificity 61%, accuracy 71%) and 24% of methylation (sensitivity 72%, specificity 61%, accuracy 71%), respectively. On multivariate analyses, corrected for age, KPS, type of surgery and second surgery, the MGMT cut-off values remained significantly correlated to longer PFS (HR = 0.5, 95%CI 0.4-0.7) and OS (HR = 0.47, 95% CI 0.3-0.6). Conclusions: From this large, multicenter study, we identify, by pyrosequencing approach, a strong prognostic value of MGMT methylation, in terms of PFS and OS. This value could be used as stratification factor in prospective clinical trials.


  • Open Access

    Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists

    by Loredana Urso, Ilaria Cavallari, Micol Silic-Benussi, Lorena Biasini, Giulia Zago, Fiorella Calabrese, Pier Franco Conte, Vincenzo Ciminale, Giulia Pasello

    // <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Loredana Urso1, Ilaria Cavallari2, *, Micol Silic-Benussi2, *, Lorena Biasini2, Giulia Zago3, Fiorella Calabrese4, Pier Franco Conte1, 3, Vincenzo Ciminale1, 2 and Giulia Pasello3 1Department of Surgery, Oncology and Gastroenterology, University of Padova, 35128, Padova, Italy 2Immunology and Molecular Oncology Unit, Veneto Institute of Oncology, IRCCS, 35128, Padova, Italy 3Medical Oncology Unit 2, Veneto Institute of Oncology, IRCCS, 35128, Padova, Italy 4Department of Cardio-Thoracic and Vascular Sciences, University of Padova, 35128, Padova, Italy *These authors contributed equally to this work Correspondence to: Vincenzo Ciminale, email: v.ciminale@unipd.it Keywords: mesothelioma, MDM2, p53, RG7112, TRAIL Received: March 10, 2017 Accepted: April 24, 2017 Published: May 11, 2017 ABSTRACT Malignant Pleural Mesothelioma (MPM) is a chemoresistant tumor characterized by low rate of p53 mutation and upregulation of Murine Double Minute 2 (MDM2), suggesting that it may be effectively targeted using MDM2 inhibitors. In the present study, we investigated the anticancer activity of the MDM2 inhibitors Nutlin 3a (in vitro) and RG7112 (in vivo), as single agents or in combination with rhTRAIL. In vitro studies were performed using MPM cell lines derived from epithelioid (ZL55, M14K), biphasic (MSTO211H) and sarcomatoid (ZL34) MPMs. In vivo studies were conducted on a sarcomatoid MPM mouse model. In all the cell lines tested (with the exception of ZL55, which carries a biallelic loss-of-function mutation of p53), Nutlin 3a enhanced p21, MDM2 and DR5 expression, and decreased survivin expression. These changes were associated to cell cycle arrest but not to a significant induction of apoptosis. A synergistic pro-apoptotic effect was obtained through the association of rhTRAIL in all the cell lines harboring functional p53. This synergistic interaction of MDM2 inhibitor and TRAIL agonist was confirmed using a mouse preclinical model. Our results suggest that the combined targeting of MDM2 and TRAIL might provide a novel therapeutic option for treatment of MPM patients, particularly in the case of sarcomatoid MPM with MDM2 overexpression and functional inactivation of wild-type p53.


  • Open Access

    Evidence of the causal role of human papillomavirus type 58 in an oropharyngeal carcinoma

    by Lorena Baboci, Paolo Boscolo-Rizzo, Dana Holzinger, Roberta Bertorelle, Lorena Biasini, Angelika Michel, Markus Schmitt, Giacomo Spinato, Rossana Bussani, Laia Alemany, et al.

    Persistent human papillomavirus infection (HPV) is recognized as an important etiologic factor for a subset of head and neck squamous cell carcinomas (SCC), especially those arising from the oropharynx. Whereas HPV16 accounts for the majority of HPV DNA-positive oropharyngeal SCC, infections with other mucosal high-risk HPV types are quite rare and biological data demonstrating their causal involvement are insufficient. Here we present the first case of an oropharyngeal SCC driven by HPV type 58. A 69-year-old Caucasian woman presented with an enlarged and firm left tonsil. A computed tomography scan showed a left tonsillar mass, extending to the soft palate and the glossotonsillar sulcus. The patient underwent extended radical tonsillectomy and ipsilateral selective neck dissection. Pathology confirmed an infiltrating, poorly differentiated SCC of the left tonsil with node metastasis (pT2N1). Adjuvant external beam radiation therapy (60 Grays (Gy)) was administered. After 1 year of follow-up, the patient is well with no evidence of cancer recurrence. HPV analyses of the tumor tissue by BSGP5+/6+ −PCR/MPG, targeting 51 mucosal HPV types, showed single positivity for HPV type 58. Presence of HPV58 E6*I RNA demonstrated biological activity of the virus in the tumor tissue, and presence of serum antibodies to HPV58 oncoproteins E6 and E7 indicated presence of an HPV58-driven cancer. Overexpression of cellular protein p16INK4a and reduced expression of pRb, two cellular markers for HPV-induced cell transformation, were observed. Exons 4–10 of TP53 showed no mutations or polymorphisms. The presence of HPV58 as single HPV infection in combination with a broad variety of direct and indirect markers of HPV transformation provides comprehensive evidence that this oropharyngeal SCC was driven by HPV58.


  • Open Access

    Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer

    by R Bertorelle, M Briarava, E Rampazzo, L Biasini, M Agostini, I Maretto, S Lonardi, M L Friso, C Mescoli, V Zagonel, et al.

    Background: Methods: Results: Conclusion:


  • Widespread Increase in Myeloid Calcifying Cells Contributes to Ectopic Vascular Calcification in Type 2 Diabetes

    by Gian Paolo Fadini, Mattia Albiero, Lisa Menegazzo, Elisa Boscaro, Saula Vigili de Kreutzenberg, Carlo Agostini, Anna Cabrelle, Gianni Binotto, Marcello Rattazzi, Elisa Bertacco, et al.

    Rationale:: Acquisition of a procalcific phenotype by resident or circulating cells is important for calcification of atherosclerotic plaques, which is common in diabetes. Objective:: We aim to identify and characterize circulating calcifying cells, and to delineate a pathophysiological role for these cells in type 2 diabetes. Methods and Results:: We demonstrate for the first time that a distinct subpopulation of circulating cells expressing osteocalcin and bone alkaline phosphatase (OC + BAP + ) has procalcific activity in vitro and in vivo. The study of naïve patients with chronic myeloid leukemia indicated that OC + BAP + cells have a myeloid origin. Myeloid calcifying OC + BAP + cells (MCCs) could be differentiated from peripheral blood mononuclear cells, and generation of MCCs was closely associated with expression of the osteogenic transcription factor Runx2. In gender-mismatched bone marrow–transplanted humans, circulating MCCs had a much longer half-life compared with OC − BAP − cells, suggesting they belong to a stable cell repertoire. The percentage of MCCs was higher in peripheral blood and bone marrow of type 2 diabetic patients compared with controls but was lowered toward normal levels by optimization of glycemic control. Furthermore, diabetic carotid endoarterectomy specimens showed higher degree of calcification and amounts of cells expressing OC and BAP in the α-smooth muscle actin–negative areas surrounding calcified nodules, where CD68 + macrophages colocalize. High glucose increased calcification by MCCs in vitro, and hypoxia may regulate MCC generation in vitro and in vivo. Conclusions:: These data identify a novel type of blood-derived procalcific cells potentially involved in atherosclerotic calcification of diabetic patients.